- Home
- EPOW vs MDCX Comparison
EPOW vs MDCX Comparison
Compare EPOW & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EPOW | MDCX |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.6M | 31.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | EPOW | MDCX |
|---|---|---|
| Price | $0.91 | $1.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.50 |
| AVG Volume (30 Days) | 146.3K | ★ 273.1K |
| Earning Date | 05-15-2025 | 02-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $70,681,651.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 51.60 | N/A |
| 52 Week Low | $0.76 | $1.28 |
| 52 Week High | $1.86 | $8.94 |
Technical Indicators
Market Signals| Indicator | EPOW | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 39.57 | 30.27 |
| Support Level | $0.90 | $1.31 |
| Resistance Level | $1.03 | $1.48 |
| Average True Range (ATR) | 0.05 | 0.12 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 5.97 | 16.69 |
Price Performance
Historical ComparisonAbout EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.